Zamerovimab Biosimilar - Research Grade

Human

RABVï؟½

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

Blue ice

Rabies virus (RABV) glycoprotein is the principal neutralizing antigen studied in rabies immunology and antiviral antibody research. This recombinant human IgG1 monoclonal is an unconjugated, non-therapeutic analog of zamerovimab directed against RABV and is supplied strictly for research use only (RUO). It is purified to a low-endotoxin standard suitable for in vivo work and prepared in scalable milligram to gram quantities to support bulk and high-throughput laboratories. The antibody is well suited to virus-neutralization assays, glycoprotein-binding studies, positive-control applications, and preclinical infection models, with no clinical purpose implied.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks